Autopsy report · NCT00158704
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
Cause of deathRegulatory or ethics
“The study stopped due to marketing approval by the FDA.”
Life of this trial
- Registered 3 years 8 months after it had already started.
- Ran for about 3 years before it stopped.
- 400 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Gilead Sciences
- Sponsor type
- Industry
- Conditions
- Hepatitis B
- Interventions
- Hepsera
- Participants
- 400
Trials that died the same way
- A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis
“FDA requested us to stop the study” - Pre-emptive Anakinra for Cytokine Event Reduction
“The trial has been stopped pending FDA approval of modifications to the trial protocol.” - Medication Use Among American Indians Adults
“The study has not been stopped. The study does not qualify as a clinical trial so it was withdrawn from clinicaltrials.gov.” - Panobinostat/Velcade in Multiple Myeloma
“This study was terminated because the drug company stopped making the study drug” - A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease
“Study stopped due to business reasons, following full enrollment of the first dose cohort.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.